Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts
Blood Purification · 2025
DOI: 10.1159/000549111 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Blood Purification, 2025. Verfasst von Natalja L Stanski und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Continuous Renal Replacement Therapy, Multiple Organ Failure, Renal Replacement Therapy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, FDA HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The selective cytopheretic device (SCD) is a cell-directed extracorporeal therapy approved for use in children with acute kidney injury (AKI) receiving continuous renal replacement therapy (CRRT) with sepsis/sepsis-like conditions. We compared outcomes for children treated with SCD to a contemporary cohort of children treated with CRRT alone.
Methods
Secondary analysis and comparison of patients ≤22 years old and ≥10 kg from a multicenter registry of patients receiving CRRT for AKI and/or fluid overload (WE-ROCK; 2015–2021) to patients from two multicenter, prospective, interventional studies of children with AKI and multiple organ dysfunction (MODS) receiving SCD (SCD-PED-01/SCD-PED-02; 2016–2022).
Results
Eighteen patients in the SCD cohort were compared to 178 in the CRRT cohort. There were no differences between cohorts at CRRT ± SCD initiation. SCD patients had shorter CRRT duration (6 [3, 11] vs. 10 [5, 18] days, p = 0.013) and shorter ICU length of stay (LOS) in survivors (16 [11, 25] vs. 27 [16, 46] days, p = 0.012). Survival to ICU discharge or day 60 was 94% in the SCD cohort vs. 74% in the CRRT cohort (p = 0.079). A Bayesian analysis demonstrated a >99% probability of improved survival with SCD. A sub-analysis in septic patients demonstrated greater survival (100% vs. 69%, p = 0.032), shorter CRRT duration (5 [3, 7] vs. 11 [6, 17] days, p = 0.006) and reduced ICU LOS in survivors (21 [10, 25] vs. 27 [16, 45] days, p = 0.027) in SCD-treated patients.
Conclusions
The addition of SCD therapy in children with AKI and MODS receiving CRRT may be beneficial, though larger prospective studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Division Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Division of Nephrology, Department of Pediatrics, Stanford University and Lucile Packard Children's Hospital Stanford, Palo Alto, California, USA, shinam@stanford.edu.
- Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NIGMS NIH HHS
- FDA HHS
Zitieren
APA
Stanski, N. L., Seo, J., Jenkins, T., Krallman, K. A., Menon, S., Humes, H. D., Askenazi, D. J., Basu, R. K., Akcan-Arikan, A., Goldstein, S. L., & Gist, K. M. (2025). Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts. Blood Purification. https://doi.org/10.1159/000549111
Vancouver
Stanski NL, Seo J, Jenkins T, Krallman KA, Menon S, Humes HD, et al. Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts. Blood Purification. 2025. doi:10.1159/000549111
BibTeX
@article{Stanski2025,
author = {Stanski, Natalja L and Seo, JangDong and Jenkins, Todd and Krallman, Kelli A and Menon, Shina and Humes, H David and Askenazi, David J and Basu, Rajit K and Akcan-Arikan, Ayse and Goldstein, Stuart L and Gist, Katja M},
title = {Use of the Selective Cytopheretic Device with Continuous Renal Replacement Therapy in Children: A Comparison of Contemporary Cohorts},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000549111}
}
EUVIMED